Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.9 USD 0.85% Market Closed
Market Cap: 339.2m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kamada Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
EPS (Diluted)
$0
CAGR 3-Years
52%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
EPS (Diluted)
$0
CAGR 3-Years
10%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
EPS (Diluted)
-$2
CAGR 3-Years
19%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
EPS (Diluted)
$0
CAGR 3-Years
32%
CAGR 5-Years
24%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
EPS (Diluted)
â‚Ş0
CAGR 3-Years
17%
CAGR 5-Years
-6%
CAGR 10-Years
0%
Pluri Inc
NASDAQ:PLUR
EPS (Diluted)
-$3
CAGR 3-Years
33%
CAGR 5-Years
26%
CAGR 10-Years
19%
No Stocks Found

Kamada Ltd
Glance View

Market Cap
339.1m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.83 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Kamada Ltd's EPS (Diluted)?
EPS (Diluted)
0.3 USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's EPS (Diluted) amounts to 0.3 USD.

What is Kamada Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-20%

Over the last year, the EPS (Diluted) growth was 180%. The average annual EPS (Diluted) growth rates for Kamada Ltd have been 52% over the past three years , -20% over the past five years .

Back to Top